Scientific Advisory Board
We work with some of the leading minds in medicine and data science to create a new standard for quality measurement. Our Scientific Advisory Board is comprised of physicians and data scientists from the country’s top academic institutions. These leaders provide insight into the latest scientific research, clinical guidelines and quality measures to help Embold identify the factors shown to consistently deliver the best results for patients.
Scientific Advisory Board Co-Chairs
Dr. Matthew Resnick
Chief Medical Officer of Embold Health
Dr. Arnie Milstein
Professor of Medicine at Stanford University
Scientific Advisory Board Members:
Kevin Bozic, MD, MBA
Chair, Department of Surgery and Perioperative Care,
UT Austin Dell Medical School
Doug Blayney, MD
Professor of Medicine,
Stanford University
Karen DeSalvo, MD
Professor of Medicine and Population Health,
UT Austin Dell Medical School
Daniel Duffy, MD
Professor of Medicine,
University of Oklahoma School of Medicine
Scott Ramsey, MD, PhD
Director,
Hutchinson Institute for Cancer Outcomes Research
Dena Bravata, MD
Former CMO,
Castlight Health
Scott Zeger, PhD
Professor of Biostatistics,
Johns Hopkins Bloomberg School of Public Health
Earl Steinberg, MD
Former CEO,
xG Soultions,
Former EVP,
Geisinger Health
Michael van Duren, MD, MBA
Clinical Variation Lead,
Agathos